maxillary sinus augmentation due to bone resorbtion. Other osteopathies
Conditions
Interventions
Intervention 1: control group: use of bio-oss in sinus augmentation. Intervention 2: Intervention:use of ostim in sinus augmentation.
Treatment - Surgery
control group: use of bio-oss in sinus augmentation
Intervention:use of ostim in sinus augmentation
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria; maxillary partial (unilateral or bilateral) edentulism or complete edentulism; Rresidual bone height between the sinus floor and the alveolar crest less than 5 mm. The exclusion criteria: smokers; pregnant women; maxillary sinus pathology; cystic lesions of the maxillary sinus; systemic disease; e.g unstable diabetes; heart disease; malignancies; radiotherapy for head and neck especially maxilla; autoimmune diseases; metabolic diseases that becomes difficult to the healing of the soft and hard tissue (e.g osteoporosis, hyperparathyroidism ,...); steroids and immunosuppressive drugs; bisphosphonates drug; untreated periodontal disease and periapical disease especially in teeth; which are close to the sinuses.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| New bone formation after sinus augmentation. Timepoint: After 5 month. Method of measurement: Microscope. | — |
Secondary
| Measure | Time frame |
|---|---|
| Residual bone graft after 5 month. Timepoint: After 5 month. Method of measurement: microscope.;Bone density. Timepoint: After 5 month. Method of measurement: CBCT. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNasrin Rahmanpour
Tabriz University of Medical Sciences
Outcome results
None listed